Conmed (CNMD) Common Equity (2016 - 2025)
Historic Common Equity for Conmed (CNMD) over the last 16 years, with Q4 2025 value amounting to $1.0 billion.
- Conmed's Common Equity rose 731.46% to $1.0 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $1.0 billion, marking a year-over-year increase of 731.46%. This contributed to the annual value of $1.0 billion for FY2025, which is 731.46% up from last year.
- Conmed's Common Equity amounted to $1.0 billion in Q4 2025, which was up 731.46% from $1.0 billion recorded in Q3 2025.
- In the past 5 years, Conmed's Common Equity ranged from a high of $1.0 billion in Q4 2025 and a low of $673.0 million during Q2 2022
- For the 5-year period, Conmed's Common Equity averaged around $837.6 million, with its median value being $792.9 million (2022).
- As far as peak fluctuations go, Conmed's Common Equity tumbled by 960.79% in 2022, and later soared by 1716.78% in 2024.
- Quarter analysis of 5 years shows Conmed's Common Equity stood at $785.4 million in 2021, then dropped by 5.08% to $745.5 million in 2022, then grew by 11.89% to $834.2 million in 2023, then grew by 15.4% to $962.7 million in 2024, then grew by 7.31% to $1.0 billion in 2025.
- Its last three reported values are $1.0 billion in Q4 2025, $1.0 billion for Q3 2025, and $1.0 billion during Q2 2025.